A. Rogier van der Velde

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure

A. Rogier van der Velde, Lars Gullestad, Thor Ueland et al. · Circulation Heart Failure · 2013 · 213 citations

Medicine, Cardiology, Internal Medicine +13

Variability Of Biomarkers in Patients with Chronic Heart Failure and Healthy Controls

Wouter C. Meijers, A. Rogier van der Velde, Anneke C. Muller Kobold et al. · European Journal of Heart Failure · 2016 · 139 citations · Full text

Medicine, Cardiology, Molecular Diagnostics +14

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis

Wouter C. Meijers, A. Rogier van der Velde, Willem P.T. Ruifrok et al. · Journal of the American Heart Association · 2014 · 65 citations · Full text

Life Sciences, Biochemistry, Physiology +13

Serial galectin-3 and future cardiovascular disease in the general population

A. Rogier van der Velde, Wouter C. Meijers, Jennifer E. Ho et al. · Heart · 2016 · 55 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy

Anne-Roos S. Frenay, Lili Yu, A. Rogier van der Velde et al. · American Journal of Physiology-Renal Physiology · 2014 · 54 citations

Medicine, Nephrology, Pharmacology +17